Evidence map›Paper›PMID 34316620›Full record

ArticleClinical parkinsonism & related disorders2020

Characterization of cognition in mild cognitive impairment with and without Parkinson's disease.

N Auclair-Ouellet, S Mandl, M Kibreab, A Haffenden, A Hanganu, J Cheetham, I Kathol, J Sarna, D Martino, O Monchi

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical parkinsonism & related disorders, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

N Auclair-OuelletSchool of Communication Sciences and Disorders, Faculty of Medicine, McGill University, Montreal, Canada.
S MandlCentre for Research on Brain, Language and Music, Montreal, Canada.
M KibreabDepartment of Clinical Neurosciences, Cumming School of Medicine, University of Calgary, Calgary, Canada.
A HaffendenDepartment of Clinical Neurosciences, Cumming School of Medicine, University of Calgary, Calgary, Canada.
A HanganuCentre de recherche de l'Institut universitaire de gériatrie de Montréal, Montreal, Canada.
J CheethamDepartment of Clinical Neurosciences, Cumming School of Medicine, University of Calgary, Calgary, Canada.
I KatholDepartment of Clinical Neurosciences, Cumming School of Medicine, University of Calgary, Calgary, Canada.
J SarnaDepartment of Clinical Neurosciences, Cumming School of Medicine, University of Calgary, Calgary, Canada.
D MartinoDepartment of Clinical Neurosciences, Cumming School of Medicine, University of Calgary, Calgary, Canada.
O MonchiDepartment of Clinical Neurosciences, Cumming School of Medicine, University of Calgary, Calgary, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

•Screening tests can diagnose PD-MCI but do not give detailed cognitive profiles.•Criteria based on a complete neuropsychological battery identify more PD patients with MCI.•The overall cognitive profile is similar in PD-MCI and MCI.•Neuropsychological batteries and definition of impairment cut-offs should be refined.

Identifiers

PMID34316620
PMCPMC8298772

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.